Please login to the form below

Not currently logged in
Email:
Password:

INC Research hires former Pfizer senior director

Beatrice Setnik joins CRO as VP, clinical pharmacology
INC Research Beatrice Setnik

INC Research has appointed former Pfizer senior director Dr Beatrice Setnik as VP, clinical pharmacology.

Setnik had been with pharma giant Pfizer since 2008 serving as senior director, medical development for the company's neuroscience business.

Prior to this she spent several years at Kendle in senior research positions.

In her new role at the contract research organisation (CRO) INC Research she will support the company's early phase business unit, providing scientific direction on matters related to abuse liability for investigational products.

Dr Pierre Geoffroy, VP, early phase at INC Research commented on Dr Setnik's suitability for the role.

"Dr Setnik's extensive knowledge and experience in the area of human abuse liability assessment and risk evaluation, as well as in CNS drug development, clinical trial design and strategic lifecycle management, will be instrumental in furthering the development of our abuse potential capabilities and new scientific growth strategies for early phase clinical research,” said Dr Geoffroy.

13th February 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics